Table 1 Clinical data of patients
Patient | Gender/age | Disease duration (years) | RF | ESR (mm/h) | CRP (mg/ml) | ARA | Concurrent medication |
|---|---|---|---|---|---|---|---|
EB87 | F/65 | 12 | + | 50 | 106.7 | 5 | NSAIDs |
EB88 | F/62 | 10 | + | 90 | 169.5 | 6 | NSAIDs |
EB213 | F/69 | 15 | + | 94 | 99.1 | 4 | NSAIDs, leflunomide, prednisone |
EB220 | F/57 | 20 | + | 23 | 2.3 | 4 | NSAIDy, prednisone, MTX |
EB221 | F/66 | 12 | + | 7 | 5.4 | 4 | NSAIDs, MTX |
EB227 | F/49 | 25 | + | 12 | 2.4 | 5 | Celecoxib, prednisone, MTX, leflunomide |
EB253 | F/53 | 19 | + | 38 | 40.1 | 5 | Azufildine |
EB261 | F/54 | 23 | + | 18 | 8.2 | 4 | Prednisone, MTX, alendronate |
EB266 | F/63 | 11 | + | 35 | 17.4 | 5 | NSAIDs, prednisone, azathioprin |
EB268 | F/53 | 8 | + | 25 | 14.8 | 6 | NSAIDs, MTX, etanercept (TNF-blocker) |